Literature DB >> 23877724

Historical perspectives in the diagnosis and treatment of primary immune deficiencies.

Mark Ballow1.   

Abstract

The field of Primary Immune Deficiency Disorders (PIDD) has advanced rapidly over the past several years with over 200 different gene mutations defined. With the recent institution of newborn screening for T cell deficiencies in many states and earlier recognition of the signs and symptoms of patients with immune deficiency, it is now apparent that PIDD is not as "rare" as was originally thought several decades ago. With the earlier recognition of patients with recurrent infections and various immune perturbations, advancements in the treatment of these immune deficiency disorders have led to enhanced survival and quality of life. In this issue, the diagnosis of PIDD through laboratory testing and skin manifestations is reviewed. The more recently described cellular immune deficiencies, selective immune deficiencies, and advances in the use of bone marrow transplantation in the correction of some of these immune deficiencies are discussed.

Entities:  

Mesh:

Year:  2014        PMID: 23877724     DOI: 10.1007/s12016-013-8384-9

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  11 in total

1.  [Agammaglobulinemia & alymphocytosis with atrophy of lymphatic tissue].

Authors:  W H HITZIG; Z BIRO; H BOSCH; H J HUSER
Journal:  Helv Paediatr Acta       Date:  1958-12

2.  Absence of serum gamma globulins.

Authors:  O C BRUTON; L APT; D GITLIN; C A JANEWAY
Journal:  AMA Am J Dis Child       Date:  1952-11

Review 3.  Immunodeficiency and genetic defects of pattern-recognition receptors.

Authors:  Mihai G Netea; Jos W M van der Meer
Journal:  N Engl J Med       Date:  2011-01-06       Impact factor: 91.245

4.  Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles.

Authors:  Jennifer M Puck
Journal:  J Allergy Clin Immunol       Date:  2012-01-29       Impact factor: 10.793

Review 5.  Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects.

Authors:  Karin R Engelhardt; Bodo Grimbacher
Journal:  J Allergy Clin Immunol       Date:  2012-02       Impact factor: 10.793

6.  Population prevalence of diagnosed primary immunodeficiency diseases in the United States.

Authors:  J M Boyle; R H Buckley
Journal:  J Clin Immunol       Date:  2007-06-19       Impact factor: 8.317

7.  Immunoglobulin therapy: methods of delivery.

Authors:  Mark Ballow
Journal:  J Allergy Clin Immunol       Date:  2008-09-19       Impact factor: 10.793

8.  A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside.

Authors:  Ahmed Aziz Bousfiha; Leïla Jeddane; Fatima Ailal; Waleed Al Herz; Mary Ellen Conley; Charlotte Cunningham-Rundles; Amos Etzioni; Alain Fischer; Jose Luis Franco; Raif S Geha; Lennart Hammarström; Shigeaki Nonoyama; Hans D Ochs; Chaim M Roifman; Reinhard Seger; Mimi L K Tang; Jennifer M Puck; Helen Chapel; Luigi D Notarangelo; Jean-Laurent Casanova
Journal:  J Clin Immunol       Date:  2013-05-09       Impact factor: 8.317

9.  Immunological reconstitution of sex-linked lymphopenic immunological deficiency.

Authors:  R A Gatti; H J Meuwissen; H D Allen; R Hong; R A Good
Journal:  Lancet       Date:  1968-12-28       Impact factor: 79.321

Review 10.  Therapeutic use of immunoglobulins.

Authors:  E Richard Stiehm; Jordan S Orange; Mark Ballow; Heather Lehman
Journal:  Adv Pediatr       Date:  2010
View more
  3 in total

1.  Primary immunodeficiencies in Central and Eastern Europe-the power of networking Report on the activity of the Jeffrey Modell Foundation Centers Network in Central and Eastern Europe.

Authors:  A Sediva; M Bataneant; M Belevtsev; A Blaziene; P Ciznar; E Förster-Waldl; J Kelecic; J Marodi; E Naumova; G Nasrullayeva; K Ress; M Serban; B Sitkauskiene; B Toth; V Modell; F Modell; V Tenembaum; M Marković; T Avcin
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

Review 2.  Autoimmunity in 2014.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

Review 3.  Fcγ Receptor Heterogeneity in Leukocyte Functional Responses.

Authors:  Carlos Rosales
Journal:  Front Immunol       Date:  2017-03-20       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.